PlainRecalls
FDA Drug Moderate Class II Terminated

Clobazam Tablets, 10 mg, CIV, 100-count bottle, Rx only, Manufactured by Centaur Pharmaceuticals Pvt. Ltd., Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037, NDC 51991-900-01

Reported: March 22, 2023 Initiated: March 2, 2023 #D-0462-2023

Product Description

Clobazam Tablets, 10 mg, CIV, 100-count bottle, Rx only, Manufactured by Centaur Pharmaceuticals Pvt. Ltd., Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037, NDC 51991-900-01

Reason for Recall

CGMP Deviations: Potential risk of Cross Contamination

Details

Units Affected
N/A
Distribution
USA nationwide.
Location
Berlin, CT

Frequently Asked Questions

What product was recalled?
Clobazam Tablets, 10 mg, CIV, 100-count bottle, Rx only, Manufactured by Centaur Pharmaceuticals Pvt. Ltd., Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037, NDC 51991-900-01. Recalled by Breckenridge Pharmaceutical, Inc. Units affected: N/A.
Why was this product recalled?
CGMP Deviations: Potential risk of Cross Contamination
Which agency issued this recall?
This recall was issued by the FDA Drug on March 22, 2023. Severity: Moderate. Recall number: D-0462-2023.